Evidence map›Paper›PMID 35546211›Full record

Observational studyDiabetologia2022

Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.

Verónica Perea, Maria José Picón, Ana Megia, Maria Goya, Ana Maria Wägner, Begoña Vega, Nuria Seguí, Maria Dolores Montañez, Irene Vinagre

Open access · bronzeAbstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Diabetologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Verónica PereaEndocrinology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain. vperea@mutuaterrassa.cat.ORCID http://orcid.org/0000-0001-8104-7326
Maria José PicónEndocrinology Department, Hospital Universitario Virgen de la Victoria, IBIMA, Málaga, Spain.ORCID https://orcid.org/0000-0001-7057-7962
Ana MegiaEndocrinology Department, Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.ORCID https://orcid.org/0000-0002-5101-9452
Maria GoyaObstetrics and Gynaecology Department, Hospital Universitari Vall d' Hebrón, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4001-2017
Ana Maria WägnerEndocrinology Department, Complejo Hospitalario Universitario Insular Materno Infantil de Canarias, Las Palmas de Gran Canaria, Spain.ORCID https://orcid.org/0000-0002-7663-9308
Begoña VegaInstituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.ORCID https://orcid.org/0000-0001-7656-6615
Nuria SeguíDiabetes Unit, Endocrinology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Maria Dolores MontañezObstetrics and Gynaecology Department, Hospital 12 de Octubre, Madrid, Spain.
Irene VinagreDiabetes Unit, Endocrinology Department, Hospital Clínic de Barcelona, Barcelona, Spain. ivinagre@clinic.cat.ORCID https://orcid.org/0000-0001-8760-3370
Hospital Clínic de Barcelona · ESInstituto de Salud Carlos III · ESUniversidad de Las Palmas de Gran Canaria · ESUniversity Hospital Mútua de Terrassa · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisThe aim of this study was to assess whether the addition of intermittently scanned continuous glucose monitoring (isCGM) to standard care (self-monitoring of blood glucose [SMBG] alone) improves glycaemic control and pregnancy outcomes in women with type 1 diabetes and multiple daily injections.

methodsThis was a multicentre observational cohort study of 300 pregnant women with type 1 diabetes in Spain, including 168 women using SMBG (standard care) and 132 women using isCGM in addition to standard care. In addition to HbA

resultsThe isCGM group had a lower median HbA CONCLUSIONS/

interpretationisCGM use provided an initial improvement in glycaemic control that was not sustained. Furthermore, offspring of isCGM users were more likely to have neonatal hypoglycaemia, with similar rates of macrosomia and prematurity to those of women receiving standard care.

Indexed as

Blood Glucose Self-MonitoringDiabetes Mellitus, Type 1Glycemic ControlPregnancy in DiabeticsPregnancy OutcomeBlood GlucoseCesarean SectionCohort StudiesFemaleFetal MacrosomiaGlycated HemoglobinHumansHypoglycemiaInfant, NewbornPregnancyWeight GainBlood GlucoseGlycated HemoglobinHbA1cIntermittently scanned continuous glucose monitoringLarge-for-gestational-ageNeonatal hypoglycaemiaPregnancyType 1 diabetes

Identifiers

PMID35546211
OpenAlexW4280531151

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.